A novel TB vaccine; towards a strategy based on our understanding of BCG failure

被引：46

作者：

Agger, EM ^{[1
]}

Andersen, P ^{[1
]}

机构：

[1] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen S, Denmark

来源：

VACCINE | 2002年 / 21卷 / 1-2期

关键词：

Mycobacterium tuberculosis; vaccination; BCG;

D O I：

10.1016/S0264-410X(02)00447-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The protection afforded by the currently available tuberculosis vaccine, bacillus Calmette-Guerin (BCG) is insufficient and new vaccine strategies are urgently needed. Progress in our understanding of the immunological deficits of BCG combined with novel knowledge on genetics of mycobacteria has paved the way for promising new vaccine strategies. These include recombinant modified BCG vaccines, attenuated strains of Mycobacterium tuberculosis, and various non-live candidates such as DNA and subunit vaccines. Decisive for transforming technical progress into a novel tuberculosis (TB) vaccine strategy is the recent advance in our understanding of the failure of BCG in the third world and the interaction between this vaccine and environmental mycobacteria. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：7 / 14

页数：8

共 80 条

[1] Tuberculosis subunit vaccine development:: on the role of interferon-γ [J].

Agger, EM ;

Andersen, P .

VACCINE, 2001, 19 (17-19) :2298-2302

[2] Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4+ T cells [J].

Alderson, MR ;

Bement, T ;

Day, CH ;

Zhu, LQ ;

Molesh, D ;

Skeiky, YAW ;

Coler, R ;

Lewinsohn, DM ;

Reed, SG ;

Dillon, DC .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (03) :551-559

[3] DOES THE PROTECTIVE EFFECT OF NEONATAL BCG CORRELATE WITH VACCINE-INDUCED TUBERCULIN REACTION [J].

ALKASSIMI, FA ;

ALHAJJAJ, MS ;

ALORAINEY, IO ;

BAMGBOYE, EA .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (05) :1575-1578

[4] EFFECTIVE VACCINATION OF MICE AGAINST MYCOBACTERIUM-TUBERCULOSIS INFECTION WITH A SOLUBLE MIXTURE OF SECRETED MYCOBACTERIAL PROTEINS [J].

ANDERSEN, P .

INFECTION AND IMMUNITY, 1994, 62 (06) :2536-2544

[5]

ANDERSEN P, 1995, J IMMUNOL, V154, P3359

[6] Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis [J].

Behar, SM ;

Dascher, CC ;

Grusby, MJ ;

Wang, CR ;

Brenner, MB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) :1973-1980

[7] Comparative genomics of BCG vaccines by whole-genome DNA microarray [J].

Behr, MA ;

Wilson, MA ;

Gill, WP ;

Salamon, H ;

Schoolnik, GK ;

Rane, S ;

Small, PM .

SCIENCE, 1999, 284 (5419) :1520-1523

[8] A historical and molecular phylogeny of BCG strains [J].

Behr, MA ;

Small, PM .

VACCINE, 1999, 17 (7-8) :915-922

[9] BCG - different strains, different vaccines? [J].

Behr, MA .

LANCET INFECTIOUS DISEASES, 2002, 2 (02) :86-92

[10]

BEHR MA, 1997, NATURE, V389

← 1 2 3 4 5 6 7 8 →